Application 211823

Type
ANDA
Sponsor
ALEMBIC PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OSELTAMIVIR PHOSPHATEOSELTAMIVIR PHOSPHATECAPSULE;ORALEQ 30MG BASENoNo
002OSELTAMIVIR PHOSPHATEOSELTAMIVIR PHOSPHATECAPSULE;ORALEQ 45MG BASENoNo
003OSELTAMIVIR PHOSPHATEOSELTAMIVIR PHOSPHATECAPSULE;ORALEQ 75MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
46708-413OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals LimitedANDACurrent
46708-414OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals LimitedANDACurrent
46708-415OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals LimitedANDACurrent
62332-413OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-413OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-413OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-413OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-413OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-414OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-414OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-414OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-414OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-414OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-415OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-415OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-415OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-415OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent
62332-415OSELTAMIVIROSELTAMIVIRAlembic Pharmaceuticals Inc.ANDACurrent